A prospective, randomized, multicentered controlled trial to compare the annual outcomes of patients with diabetes mellitus monitored with weekly fructosamine testing versus usual care: A 3-month interim analysis

Diabetes Technology and Therapeutics

Volumn 4, Issue 5, 2002, Pages 637-642

  Lindsey, Cameron C ^a,b   Carter, Alan W ^a,c   Mangum, Stacy ^a,d   Greene, Dorothy ^e   Richardson, Antoine ^a   Brown, Sherrill ^a   McCandless, Bridget ^b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b Jackson County Health Department   (United States)

^c Pharmacy Director   (United States)

^d Kansas City Free Health Clinic   (United States)

^e U S DEPARTMENT OF AGRICULTURE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FRUCTOSAMINE; GLUCOSE; HEMOGLOBIN A1C;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DEVICE; DIABETES CONTROL; DIABETES MELLITUS; FEMALE; FOLLOW UP; FRUCTOSAMINE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HOME MONITORING; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PATIENT CARE; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AGING; BLOOD GLUCOSE SELF-MONITORING; BODY MASS INDEX; BODY WEIGHT; CONTINENTAL POPULATION GROUPS; DIABETES MELLITUS; DOUBLE-BLIND METHOD; EXERCISE; FEMALE; FRUCTOSAMINE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF LIFE; SEX CHARACTERISTICS; TREATMENT OUTCOME;

EID: 0036412806     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/152091502320798268     Document Type: Article

References (17)

1. American Diabetes Association: Implications of the diabetes control and complications trial. Diabetes Care 2001;24(Suppl 1):S25-S27.
2. American Diabetes Association: Implications of the United Kingdom prospective diabetes study. Diabetes Care 2001;24(Suppl 1):S28-S32.
3. American Diabetes Association: Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2001;24(Suppl 1):S5-S20.
4. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2002;25(Suppl 1):S33-S49.
5. Cobin R, Ganda O, Garber J, Hellman R, Dickey R, Jellinger P, Janick J, Rodbard H, Bell D, Davidson E, Seibel J, Feld S: American College of Endocrinology Consensus Conference on Guidelines for Glycemic Control. White paper available at: www.aace.com/pub/press/releases/diabetesconsensuswhitepaper.p hp. Accessed 7:04 p.m., January 5, 2002.
6. Testa MA, Simonson DC: Health economic benefits and quality of life during improved glycemic control in patients with type 2 diabetes mellitus: A randomized, controlled, double-blind trial. JAMA 1998;280:1490-1496.
7. Harris MI, Byrd-Holt DD: Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults: The Third National Health and Nutrition Examination Survey, 1988-1994. Diabetes Care 1998;21:518-524.
8. Anonymous. Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 1998;21:296-309.
9. Carter A, Borchardt N, Cooney M, Greene D: Dual test diabetes screening project: Screening for poor glycemic control in a large workplace population. Diabetes Technol Ther 2000;2:529-536.
10. Edelman SV, Callahan P, Deeb LC: Multi-site evaluation of a new diabetes self-test for both glucose and glycated protein (fructosamine). Diabetes Technol Ther 2000;2:233-238.
11. Koch D: Fructosamine: How useful is it? Lab Med 1990;21:497-503.
12. Klonoff DC: Serum fructosamine as a screening for type 2 diabetes: An analysis. Diabetes Technol Ther 2000;2:537-539.
13. Carter A, Borchardt N, Cooney M, Greene D: Dualtest monitoring of hyperglycemia using daily glucose and weekly fructosamine values. Diabetes Technol Ther 2001;3:399-403.
14. The LXN Duet II Test System: Food and Drug Administration file K990942.
15. A1C At-Home™: Food and Drug Administration file K971919.
16. Boyer JG, Earp JL: The development of an instrument for assessing the quality of life of people with diabetes. Med Care 1997;35:440-453.
17. Coster S, Gulliford MC, Seed PT, Powrie JK, Swaminathan R: Self-monitoring in type 2 diabetes mellitus: A meta-analysis. Diabet Med 2000;17:755-761.